Treatment of Chronic Stroke With AMES + EMG Biofeedback

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 21, 2007

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
StrokePlegiaParesisCerebrovascular Accident
Interventions
DEVICE

AMES Therapy (assisted movement and enhanced sensation)

Each subject will receive 30 sessions of AMES therapy in the clinic. Each session will consist of 10 min of functional testing (i.e., passive motion and strength tests) followed by 30 min of grasp therapy using the AMES device. One group of subjects will receive AMES therapy only with joint torque biofeedback (without EMG feedback), and the other group will receive AMES therapy with EMG biofeedback. While all test subjects should attempt to open the hand when the grasp mechanism is opening and close the hand when the mechanism is closing, the biofeedback information provided to aid a subject will differ for the 2 subject groups.

Trial Locations (3)

30322

Emory University School of Medicine, Atlanta

60611

Northwestern University, Chicago

97239

Oregon Health and Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

collaborator

Emory University

OTHER

collaborator

Northwestern University

OTHER

lead

AMES Technology

INDUSTRY

NCT01116544 - Treatment of Chronic Stroke With AMES + EMG Biofeedback | Biotech Hunter | Biotech Hunter